Phase II clinical trial with long-term infusion of anti-GD2 antibody ch14.18/CHO in combination with interleukin-2 (IL2) in patients with high risk neuroblastoma.
2016 ◽
Vol 34
(15_suppl)
◽
pp. 10562-10562
◽
2007 ◽
Vol 13
(22)
◽
pp. 6696-6702
◽
2020 ◽
Vol 108
(3)
◽
pp. e874-e875
1994 ◽
Vol 15
(1)
◽
pp. 74-78
◽